Mirion Technologies, a global provider of detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced it has cleared all regulatory hurdles in connection with its pending business combination with GS Acquisition Holdings II.
GSAH and Mirion have received clearance from regulatory organizations in Finland, France and Germany. The SPAC’s stockholder vote on the deal is scheduled for Oct. 19.
Announced in June, the deal values the combination at $2.6 billion. Terms call for Mirion to receive approximately $750 million of cash held in the SPAC’s trust as well as a $900 million PIPE. In addition to a $200 million anchor PIPE investment, Goldman Sachs has provided an extra $125 million equity commitment to be used as a backstop. Read more.
